BioOrbit

BioOrbit is a UK biotech startup building a scalable platform for crystallising biologic drugs in microgravity.

Est. 2023 Startup
Visit Website
Quick Facts
Country
United Kingdom
Founded
2023
Type
startup
Status
development

About BioOrbit

Updated 2026-06-30

BioOrbit is a UK biotech startup building a scalable platform for crystallising biologic drugs in microgravity. Founded in 2023 by Katie King and Leonor Teles, the company develops BOX, a compact, autonomous, microwave-sized manufacturing unit designed to move protein crystallisation from one-off ISS experiments toward industrial-scale production. Crystallising monoclonal antibodies in orbit can yield more uniform suspensions, potentially enabling at-home subcutaneous injections instead of hospital infusions. In 2026 BioOrbit raised a 9.8 million pound seed round, described as the largest ever for in-space manufacturing.

Key People

Katie King (co-founder, CEO)

Categories & Capabilities

Location

Loading map...

Click and drag to explore • Double-click to zoom

Share

Suggest an Edit

Is this information outdated or incorrect? Help us improve this profile.

Submit Correction

Explore More

Discover 1,000+ space companies worldwide

Browse All Companies

Frequently asked about BioOrbit

Quick answers to the questions readers most often search for.

When was BioOrbit founded?
BioOrbit was founded in 2023 in United Kingdom.
Where is BioOrbit based?
BioOrbit is based in United Kingdom.
What does BioOrbit do?
BioOrbit is a UK biotech startup building a scalable platform for crystallising biologic drugs in microgravity. Founded in 2023 by Katie King and Leonor Teles, the company develops BOX, a compact, autonomous, microwave-sized manufacturing unit designed to move protein crystallisation from one-off ISS experiments toward…
Is BioOrbit a public or private company?
BioOrbit is currently a private startup (status: development).
What sector does BioOrbit operate in?
BioOrbit operates in manufacturing, research, space-technology.

Data Accuracy Notice: Information about BioOrbit is compiled from publicly available sources including company websites, press releases, regulatory filings, and industry reports. Data is reviewed periodically but may not reflect the most recent developments.

Last updated: June 30, 2026
Company representatives may submit corrections This page does not constitute an endorsement or affiliation Learn about our data methodology